Abstract: A seat rail locking device for a vehicle includes a lower rail having a plurality of locking grooves formed in an inner flange and opened downward, a locking plate having a plurality of locking teeth configured to be inserted into or withdrawn from the plurality of locking grooves when the locking plate moves upward or downward, an upper rail inserted into the lower rail so as to be slidable straight and having a locking-lifting mechanism configured to switch a locking state by moving the locking plate upward or downward, and an anti-rotation mechanism configured to suppress a rotation of the locking plate against a transverse load applied to the upper rail.

Abstract: A busbar unit electrically connected to a motor comprising a stator around which a coil is wound includes: a first terminal including a first body and a first terminal part protruding from an upper portion of the first body and electrically connected to the coil; a first holder configured to support the first terminal such that the first terminal part is exposed to an outside of the busbar unit; and a second holder disposed on an upper portion of the first holder and configured to press the coil against the first terminal part.

Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutenone as an active ingredient. Hirsutenone as the active ingredient of the present composition decreases the number of eosinophil and the level of IgE increased in atopic dermatitis and remarkably reduces expression amounts of immune regulatory cytokine (e.g., IL-4, IL-5 and IL-13) associated with atopic dermatitis. In addition, hirsutenone decreases COX-2 and iNOS expression. Hirsutenone as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis or relieving a symptom of atopic dermatitis.

Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutanonol as an active ingredient. Hirsutanonol or oregonin as the active ingredient of the present composition decreases the number of eosinophil increased in atopic dermatitis and regulates expression amounts of immune regulatory cytokines, IL-4, IL-5, IL-10 and IL-13 associated with atopic dermatitis. In addition, hirsutanonol and oregonin increase MBD (mouse beta-defensin)-1, MBD-2 and MBD-3 expression and decrease COX-2 and iNOS expression in mouse animal model of atopic dermatitis. Hirsutanonol and oregonin as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis.

Abstract: The present invention relates to a composition for treating atopic dermatitis comprising hirsutenone as an active ingredient. Hirsutenone as the active ingredient of the present composition decreases the number of eosinophil and the level of IgE increased in atopic dermatitis and remarkably reduces expression amounts of immune regulatory cytokine (e.g., IL-4, IL-5 and IL-13) associated with atopic dermatitis. In addition, hirsutenone decreases COX-2 and iNOS expression. Hirsutenone as the active ingredient of the present composition could be effectively used in drugs, cosmetics and foods for treating atopic dermatitis or relieving a symptom of atopic dermatitis.

Abstract: A remote control command response confirming apparatus which includes a remote control command reception device for performing an operation corresponding to a received command signal in response to reception of a first remote control command signal, and for transmitting a second remote control command signal in response to the received remote control command signal. The apparatus also includes a remote controller having at least one or more operable function keys and an light emitting diode (LED) lamp for each function key, for transmitting to the remote control command reception device, the first control command signal according a selected function key, and for turning off the lamp corresponding to the key in response to reception of the second remote control command signal.